NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.58) per share which missed the ana

NeOnc (Nasdaq: NTHI) will host an investor conference call and webcast on Wednesday, August 12, 2026

CALABASAS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinic

CALABASAS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI

Three emerging biotechnology companies, Can-Fite (NYSE: CANF), NeOnc (NASDAQ: NTHI), and PMGC (NASDA

DENVER, June 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASD

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a clini

Authorization covers all three NEO100 programs across adult Phase 1 through Phase 2, plus pediatric

International Regulatory Validation Has Preceded Several Recent FDA Success Stories, Though Signific

NeOnc Technologies Holdings (NASDAQ:NTHI) is rapidly emerging as a development-stage neuro-oncology

DALLAS, June 17, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is rapidly emer

DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) – NeOnc Technologies Holdings (NASDA

Clearance enables Phase 2 evaluation of NEO212, the Company's oral perillyl alcohol-temozolomide

Clearance enables Phase 2 evaluation of NEO212, the Company's oral perillyl alcohol-temozolomide con

New Funding Structure Includes Redemption Rights, Ownership Limitations, and Conversion Floor as Inv

The transactions contemplated by the Purchase Agreement are expected to close upon the satisfaction

NeOnc Technologies Advances Novel Neuro-Oncology Therapies Targeting Glioblastoma and Other Hard-to-

DENVER, May 29, 2026 (GLOBE NEWSWIRE) -- (www. 247marketnews. com) - When most investors think about

BTIG analyst Thomas Shrader reiterates NeOnc Technologies Hldgs (NASDAQ:NTHI) with a Buy and main

DENVER, May 19, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com ) – NeOnc Technologies (NASDAQ:NTHI

Alliance Global Partners analyst Matthew Venezia initiates coverage on NeOnc Technologies Hldgs (

Maxim Group analyst Jason McCarthy initiates coverage on NeOnc Technologies Hldgs (NASDAQ:NTHI) w

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.38) per share which missed the ana

CALABASAS, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI)

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp t

DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com and NeOnc Technology) - The biotech

DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- 24/7 Market News and NeOnc Technology -- As market particip

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinic

Top Wall Street analysts changed outlook on top names. See analyst ratings page for complete view. W

BTIG analyst Thomas Shrader initiates coverage on NeOnc Technologies Hldgs (NASDAQ:NTHI) with a B

Entry into a Material Definitive Agreement. At The Market Offering On April 10, 2026, the Company en

 $300,000,000Common StockPreferred StockDebt SecuritiesWarrantsRightsUnitsFrom time to time, we may

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.72) per share which missed the ana

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi